There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfizer (PFE – Research Report) and Sagimet Biosciences, Inc. Class A (SGMT – R ...

The most notable increase was in Bristol-Myers Squibb Co (NYSE:BMY), with an additional 14,342,846 shares, bringing the total ...

ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILINGPoster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour ...

The worst 2025 performer in the FTSE 100 has been hit by some fresh crises. Is it time for investors to abandon ship, or leap ...

Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

My final reason for buying more Pfizer stock is that I'll get paid nicely to wait and see if the drugmaker lives up to Wall Street's growth outlook. Pfizer's forward dividend yield currently stands at ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

The stock's fall snapped a five-day winning streak.

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. UBS analyst ...

From migraine to Parkinson’s and obesity, AbbVie is building dominant franchises across multiple high-growth areas. Read why ...